Shingles, or herpes zoster, is a common secondary infection that can impose a significant burden, impacting cerebrovascular, cardiovascular, neurologic, ophthalmic, and dermatologic systems. Therefore, despite common perceptions, shingles is more than just a rash, and its extensive burden highlights the need for an effective prevention strategy. While highly effective vaccines exist, shingles vaccination remains low. Community pharmacists play a critical role in educating at-risk patients about shingles and the availability of vaccines to prevent shingles-related complications, as well as easing the accessibility of shingles vaccination. However, barriers may impede the implementation of shingles vaccination protocols in community pharmacy settings.
This CMEOCast podcast features expert faculty focusing on best practices to increase vaccine uptake by engaging and educating patients in pharmacy settings.
At the end of this CME/CE activity, participants should be able to develop best practices to implement a shingles protocol in pharmacy settings.
The following learning objectives pertain only to those requesting CNE or CPE credit: Describe best practices for a shingles protocol in pharmacy settings.
This educational activity is supported by an educational grant from GlaxoSmithKline.
Physicians, PAs, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Schaffner has no disclosures to report.
Michael D. Hogue, PharmD, FAPhA, FNAP has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-133-H06-P.
Call us at 877.CME.PROS (877.263.7767).